Format

Send to

Choose Destination
Nat Biotechnol. 2019 Mar;37(3):232-237. doi: 10.1038/s41587-019-0042-1. Epub 2019 Feb 18.

Regenerating the field of cardiovascular cell therapy.

Author information

1
Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden. kenneth.chien@ki.se.
2
Department of Medicine, Karolinska Institutet, Stockholm, Sweden. kenneth.chien@ki.se.
3
Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden. jonas.frisen@ki.se.
4
Cardiovascular, Renal and Metabolism, IMED Biotech Unit, AstraZeneca Gothenburg, Gothenburg, Sweden. regina.fritsche-danielson@astrazeneca.com.
5
Department of Stem Cell and Regenerative Biology and Harvard Stem Cell Institute, Harvard University, Cambridge, MA, USA. dmelton@harvard.edu.
6
Howard Hughes Medical Institute, Chevy Chase, MD, USA. dmelton@harvard.edu.
7
Departments of Pathology, Bioengineering and Medicine/Cardiology, Institute for Stem Cell and Regenerative Medicine, Center for Cardiovascular Biology, University of Washington, Seattle, WA, USA. murry@uw.edu.
8
Institute for Stem Cell Biology and Regenerative Medicine; Ludwig Center for Cancer Stem Cell Biology and Medicine; Departments of Pathology and Developmental Biology, Stanford University School of Medicine, Stanford, CA, USA. irv@stanford.edu.

Abstract

The retraction of >30 falsified studies by Anversa et al. has had a disheartening impact on the cardiac cell therapeutics field. The premise of heart muscle regeneration by the transdifferentiation of bone marrow cells or putative adult resident cardiac progenitors has been largely disproven. Over the past 18 years, a generation of physicians and scientists has lost years chasing these studies, and patients have been placed at risk with little scientific grounding. Funding agencies invested hundreds of millions of dollars in irreproducible work, and both academic institutions and the scientific community ignored troubling signals over a decade of questionable work. Our collective retrospective analysis identifies preventable problems at the level of the editorial and peer-review process, funding agencies and academic institutions. This Perspective provides a chronology of the forces that led to this scientific debacle, integrating direct knowledge of the process. We suggest a science-driven path forward that includes multiple novel approaches to the problem of heart muscle regeneration.

PMID:
30778231
DOI:
10.1038/s41587-019-0042-1

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center